e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
EW19 Motivational interviewing for smoking cessation in COPD smokers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Workstation 4: The roles spirometry and lung age play in increasing the motivation of COPD patients
Carlos Andres Jimenez Ruiz (Madrid, Spain)
Source:
International Congress 2015 – EW19 Motivational interviewing for smoking cessation in COPD smokers
Session:
EW19 Motivational interviewing for smoking cessation in COPD smokers
Session type:
Educational skills workshop
Number:
3203
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Carlos Andres Jimenez Ruiz (Madrid, Spain). Workstation 4: The roles spirometry and lung age play in increasing the motivation of COPD patients. International Congress 2015 – EW19 Motivational interviewing for smoking cessation in COPD smokers
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
Prevalence of small airway dysfunction among GOLD stages in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Enablers, barriers, needs and preferences of physical activity in patients with COPD: does pulmonary rehabilitation play a role?
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
The influence of hyperinflation and systemic inflammation on the 6 minute walking distance in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
The influence of smoking on capnometry lung ventilation parameters in chronic obstructive pulmonary disease patients
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015
Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
COPD patients with exertional desaturation have a higher risk of rapid lung function decline
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Perception of the role of smoking in patients with COPD
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Physiological phenotypes of COPD: the role of resting lung volumes
Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function
Year: 2020
High rate of obstructive pulmonary function tests in adults below 40 Years of age in Germany
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
The role of interactive game-based system in pulmonary rehabilitation of patients with COPD
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept